12/15-Lipoxygenase gene disruption and Vitamin E administration diminish atherosclerosis and oxidative stress in apolipoprotein E deficient mice through a final common pathway
- 31 December 2005
- journal article
- Published by Elsevier in Prostaglandins & Other Lipid Mediators
- Vol. 78 (1-4) , 185-193
- https://doi.org/10.1016/j.prostaglandins.2005.07.003
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Vitamin E Reduces Progression of Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice With Established Vascular LesionsCirculation, 2003
- Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crimeNature Medicine, 2002
- 12/15-Lipoxygenase Gene Disruption Attenuates Atherogenesis in LDL Receptor–Deficient MiceCirculation, 2001
- Absence of 12/15-Lipoxygenase Expression Decreases Lipid Peroxidation and Atherogenesis in Apolipoprotein E–Deficient MiceCirculation, 2001
- Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E–deficient miceJournal of Clinical Investigation, 1999
- The diversity of the lipoxygenase familyFEBS Letters, 1999
- Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient miceNature Medicine, 1998
- The oxidation hypothesis of atherosclerosisThe Lancet, 1994
- Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.Journal of Clinical Investigation, 1989
- Low density lipoprotein undergoes oxidative modification in vivo.Proceedings of the National Academy of Sciences, 1989